Business Success Action Group

Australian Prime Minister's Special Envoy Tony Abbott on Friday expressed confidence that India and Australia will meet the deadline to finalize the proposed trade pact, which aims to strengthen economic ties between the two countries. India and Australia have agreed to sign a long-pending free trade agreement officially known as the Comprehensive Economic Cooperation Agreement (CECA) by the end of 2022 and an early harvest trade agreement by the end of this year. In an early harvest agreement, two trading partners significantly reduce or eliminate tariffs on a certain number of goods, these tariffs have been removed on the maximum number of goods traded between them in a free trade agreement or CECA. They also liberalize norms to improve trade in services and encourage investment in a CECA. "The main purpose of this visit is to ensure that we can get the best possible trade deal between India and Australia as soon as possible ..." "Based on discussions last night

DUBLIN, December 02, 2021 - (BUSINESS WIRE) - The report "Hypolipidemis Global Market Report 2021: COVID-19 Impact and Recovery to 2030" has been added ResearchAndMarkets.com to offer. The global hypolipidemia market is forecast to decline from $ 16.23 billion in 2020 to $ 15.94 billion in 2021, with an average annual growth rate (CAGR) of -1.8%. The decline is mainly due to the fact that companies' production was negatively impacted by COVID-19, which had previously led to restrictive containment measures involving social distancing, remote working and the closure of commercial activities that created operational challenges. The market is expected to reach $ 18.41 billion in 2025 at a CAGR of 3.7%. Key players in the Hypolipidemic Drugs market are Abbott Laboratories Ltd, Apotex Fermentation Inc., Biocon Limited, Cadila Healthcare Limited, and Chunghwa Chem Syn & Biotech Co., Ltd. Hypolipidemic Drugs market consists of hypolipidemic drug sales and related services